Delivery Order SPE2DB22D9316-SPE2DB24FYP10

Award Date 5/6/24
Potential Completion Date 5/28/24
Potential Value $32K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $48,131.04, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials by May 9, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $80,285.70 contract is for the delivery of Keytruda, a cancer immunotherapy drug, through March 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, #4600082013 under the SPE2DB program, which enables DLA to issue orders for a broad range of pharmaceutical items to meet the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $48,131.04 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial, a prescription cancer drug, with a period of performance through April 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract SPE2DB24FYN74 with DLA, valued at up to $4,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $80,218.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials, a specialized oncology medication, with a period of performance through September 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,131.04 firm fixed-price contract is for the delivery of Keytruda 100 mg/4 ml vials. This order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery orders for a wide range of...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $48,131.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 mL vials with a completion date of June 6, 2024. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued up to $499,999,999, that enables the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $80,218.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is not set-aside, is for the delivery of Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $96,262.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial, a specialized oncology medication. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) has awarded a $77,505.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,560,580,827 units of Keytruda 100 mg/4 ml vial, a cancer medication, with a performance period ending on May 3, 2023. This award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $160,571.40 contract is for the delivery of Keytruda 100 mg/4 ml vials. This delivery order falls under DMS Pharmaceutical Group's broader $4,999,999 indefinite delivery contract with DLA for a wide range of pharmaceutical products to support military health facilities worldwide. DMS Pharmaceutical Group is an...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP10
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $32,087.36, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda, a cancer immunotherapy drug, with a completion date of May 28, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a prime vendor for the DLA and the Department of Defense (DoD), providing a wide array of branded and generic prescription drugs, biologics, and medical consumables to military and VA medical facilities.

Generated 8/5/24, 9:48 AM